Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3308778 | 0.76 | ANPEP (0.37) | ANPEP | |
| SCHEMBL3989572 | 0.68 | CYP2C9 (0.43) | CYP2C9CYP2C19 | |
| SCHEMBL28304333 | 0.65 | TDP1 (0.46) | CYP2C9CYP2C19 | |
| SCHEMBL2412348 | 0.63 | CYP2C19 (0.52) | CYP2C9CYP2C19 | |
| SCHEMBL15231954 | 0.62 | CYP2C19 (0.50) | CYP2C9CYP2C19 | |
| SCHEMBL4901538 | 0.61 | ANPEP (0.38) | ANPEPCYP2C9CYP2C19 | |
| SCHEMBL4602535 | 0.61 | MAOA (0.48) | CYP2C9CYP2C19 | |
| SCHEMBL8000651 | 0.61 | CA12 (0.36) | ANPEPCYP2C9CYP2C19 | |
| Acetamide SCHEMBL2412349 | 0.60 | CYP2C19 (0.48) | CYP2C9CYP2C19 | |
| SCHEMBL26431472 | 0.60 | ANPEP (0.45) | ANPEPCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060067881-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPHYSICS ASSAY LABORATORY, INC. | 2006-03-30 | — | — | US | claimed |
| EP-1399170-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | Biophysics Assay Laboratory, Inc. (US) | 2004-03-24 | — | — | EP | claimed |
| US-20030059368-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPAL, INC. | 2003-03-27 | — | — | US | claimed |
| WO-2002062397-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | BIOPHYSICS ASSAY LABORATORY, INC. (US) | 2002-08-15 | — | — | WO | claimed |
| EP-2429593-A2 | BIOMOLECULE COMPLEXES AS CONTRAST AGENTS IN POSITRON EMISSION TOMOGRAPHY (PET) BASED METHODS FOR THE ASSESSMENT OF ORGAN FUNCTION | Bergen Teknologioverføring AS (NO) | 2012-03-21 | — | — | EP | disclosed |
| EP-2428231-A2 | Biomolecule complexes as contrast agents in Positron Emission Tomography (PET) based methods for the assessment of organ function | Bergen Teknologioverføring AS (NO) | 2012-03-14 | — | — | EP | disclosed |
| US-20100191096-A1 | PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2010-07-29 | — | — | US | disclosed |
| WO-2010066843-A2 | BIOMOLECULE COMPLEXES AS CONTRAST AGENTS IN POSITRON EMISSION TOMOGRAPHY (PET) BASED METHODS FOR THE ASSESSMENT OF ORGAN FUNCTION | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2010-06-17 | — | — | WO | disclosed |
| EP-2164523-A2 | PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION | Bergen Teknologioverforing AS (NO) | 2010-03-24 | — | — | EP | disclosed |
| WO-2008148877-A2 | PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2008-12-11 | — | — | WO | disclosed |
| US-7048907-B2 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPHYSICS ASSAY LABORATORY, INC. (US) | 2006-05-23 | — | — | US | disclosed |
| US-20060067881-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPHYSICS ASSAY LABORATORY, INC. | 2006-03-30 | — | — | US | disclosed |
| EP-1399170-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | Biophysics Assay Laboratory, Inc. (US) | 2004-03-24 | — | — | EP | disclosed |
| US-20030059368-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPAL, INC. | 2003-03-27 | — | — | US | disclosed |
| WO-2002062397-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | BIOPHYSICS ASSAY LABORATORY, INC. (US) | 2002-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060067881-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | ATP6V1B1, REN, GLS | ANPEP 542/4885CYP2C9 661/4885CYP2C19 1029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.